RNA therapeutics use RNA molecules to prevent, treat, or diagnose disease by influencing gene expression or protein production. Explore how translatomics reveals whether these therapies function effectively at the translation level in RNA drug discovery.
tRFs are emerging as key stress signals in obesity and type 2 diabetes, linking beta cell dysfunction with islet macrophage activation and revealing new clues for metabolic disease research.
Why do RNA-seq data show upregulation of a key gene while protein levels do not match? This blog explains the disconnect between transcriptomics and proteomics, and shows why translatomics helps reveal which mRNAs are actually being translated.
This website uses cookies to ensure the best experience possible. More information...